NatureCell Co.,Ltd. (KOSDAQ:007390)
South Korea · Delayed Price · Currency is KRW 22,800
-1,200 (-5.00%)
At close: Feb 6, 2026
NatureCell Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2012 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '12 Dec 31, 2012 |
Operating Revenue | 22,122 | 32,334 | 19,351 | 21,252 | 20,354 | 27,205 |
Other Revenue | 0 | 0 | - | - | -0 | - |
| 22,122 | 32,334 | 19,351 | 21,252 | 20,354 | 27,205 | |
Revenue Growth (YoY) | -22.65% | 67.09% | -8.95% | 4.41% | -25.18% | 19.35% |
Cost of Revenue | 12,799 | 15,414 | 11,160 | 12,163 | 11,114 | 24,556 |
Gross Profit | 9,323 | 16,920 | 8,191 | 9,089 | 9,241 | 2,649 |
Selling, General & Admin | 11,006 | 14,505 | 15,112 | 16,454 | 15,052 | 2,682 |
Research & Development | 56.88 | 338.9 | 2,221 | 1,577 | 1,473 | - |
Amortization of Goodwill & Intangibles | 8.14 | 6.11 | 4.31 | 3.85 | 3.2 | - |
Other Operating Expenses | 60.08 | 63.2 | 50.33 | 87.35 | -66.38 | 48.75 |
Operating Expenses | 12,512 | 16,316 | 18,411 | 15,785 | 17,706 | 3,106 |
Operating Income | -3,190 | 604.01 | -10,220 | -6,696 | -8,465 | -457.26 |
Interest Expense | -170.08 | -168.04 | -1,147 | -1,724 | -750.69 | - |
Interest & Investment Income | 716.48 | 859.8 | 731.36 | 343.37 | 92.11 | 12.41 |
Earnings From Equity Investments | - | - | -61.21 | -1,106 | -360.01 | - |
Currency Exchange Gain (Loss) | 123.39 | 255.71 | 92.35 | 44.94 | 91.76 | -151.22 |
Other Non Operating Income (Expenses) | -178.9 | -196.51 | -838.02 | -918.18 | -15,896 | -1,347 |
EBT Excluding Unusual Items | -2,699 | 1,355 | -11,443 | -10,055 | -25,289 | -1,943 |
Gain (Loss) on Sale of Investments | - | - | -357.21 | 1,710 | -4,156 | - |
Gain (Loss) on Sale of Assets | -39.16 | -0.05 | 276.5 | 29.36 | - | -0.05 |
Asset Writedown | - | - | - | - | -569.55 | - |
Other Unusual Items | - | - | -47.43 | - | - | - |
Pretax Income | -2,738 | 1,355 | -11,571 | -8,316 | -30,014 | -1,943 |
Income Tax Expense | 128.82 | 128.77 | -132.64 | - | - | -43.83 |
Earnings From Continuing Operations | -2,867 | 1,226 | -11,438 | -8,316 | -30,014 | -1,899 |
Earnings From Discontinued Operations | - | - | -242.25 | 1,502 | -2,016 | - |
Net Income | -2,867 | 1,226 | -11,680 | -6,814 | -32,031 | -1,899 |
Net Income to Common | -2,867 | 1,226 | -11,680 | -6,814 | -32,031 | -1,899 |
Shares Outstanding (Basic) | 64 | 64 | 64 | 63 | 62 | 25 |
Shares Outstanding (Diluted) | 64 | 64 | 64 | 63 | 62 | 25 |
Shares Change (YoY) | 0.33% | 1.21% | 1.46% | 1.43% | 143.89% | 9.20% |
EPS (Basic) | -44.51 | 19.09 | -183.80 | -108.78 | -518.71 | -75.00 |
EPS (Diluted) | -44.52 | 19.06 | -183.80 | -108.78 | -518.71 | -75.00 |
Free Cash Flow | -855.13 | -1,590 | -8,253 | -18,659 | -10,533 | -2,741 |
Free Cash Flow Per Share | -13.28 | -24.73 | -129.86 | -297.89 | -170.58 | -108.27 |
Gross Margin | 42.14% | 52.33% | 42.33% | 42.77% | 45.40% | 9.74% |
Operating Margin | -14.42% | 1.87% | -52.81% | -31.51% | -41.59% | -1.68% |
Profit Margin | -12.96% | 3.79% | -60.36% | -32.06% | -157.37% | -6.98% |
Free Cash Flow Margin | -3.86% | -4.92% | -42.65% | -87.80% | -51.75% | -10.08% |
EBITDA | -1,319 | 2,504 | -8,469 | -5,364 | -6,617 | -164.78 |
EBITDA Margin | -5.96% | 7.74% | -43.77% | -25.24% | -32.51% | -0.61% |
D&A For EBITDA | 1,870 | 1,900 | 1,751 | 1,332 | 1,848 | 292.48 |
EBIT | -3,190 | 604.01 | -10,220 | -6,696 | -8,465 | -457.26 |
EBIT Margin | -14.42% | 1.87% | -52.81% | -31.51% | -41.59% | -1.68% |
Effective Tax Rate | - | 9.50% | - | - | - | - |
Advertising Expenses | - | 2,943 | 3,185 | 543.12 | 1,904 | 68.22 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.